<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
        <PMID Version="1">25534722</PMID>
        <DateCompleted>
            <Year>2015</Year>
            <Month>12</Month>
            <Day>01</Day>
        </DateCompleted>
        <DateRevised>
            <Year>2018</Year>
            <Month>12</Month>
            <Day>02</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-6596</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>59</Volume>
                    <Issue>3</Issue>
                    <PubDate>
                        <Year>2015</Year>
                        <Month>Mar</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Antimicrobial agents and chemotherapy</Title>
                <ISOAbbreviation>Antimicrob. Agents Chemother.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Fidaxomicin therapy in critically ill patients with Clostridium difficile infection.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1776-81</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1128/AAC.04268-14</ELocationID>
            <Abstract>
                <AbstractText>Fidaxomicin use to treat proven Clostridium difficile infection (CDI) was compared between 20 patients receiving care in critical care units (CCUs) and 30 patients treated on general medical floors. At baseline, the CCU patients had more initial CDI episodes, more severe and complicated disease, and more concurrent broad-spectrum antibiotic coverage. On multivariate analysis, the response to fidaxomicin therapy among the critically ill patients was comparable to that among patients in the general medical wards. </AbstractText>
                <CopyrightInformation>Copyright Â© 2015, American Society for Microbiology. All Rights Reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Penziner</LastName>
                    <ForeName>Samuel</ForeName>
                    <Initials>S</Initials>
                    <AffiliationInfo>
                        <Affiliation>New York University Langone Medical Center and New York University School of Medicine, New York, New York.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dubrovskaya</LastName>
                    <ForeName>Yanina</ForeName>
                    <Initials>Y</Initials>
                    <AffiliationInfo>
                        <Affiliation>New York University Langone Medical Center and New York University School of Medicine, New York, New York.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Press</LastName>
                    <ForeName>Robert</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>New York University Langone Medical Center and New York University School of Medicine, New York, New York.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Safdar</LastName>
                    <ForeName>Amar</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>New York University Langone Medical Center and New York University School of Medicine, New York, New York amar.safdar@nyumc.org.</Affiliation>
                    </AffiliationInfo>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>12</Month>
                <Day>22</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Antimicrob Agents Chemother</MedlineTA>
            <NlmUniqueID>0315061</NlmUniqueID>
            <ISSNLinking>0066-4804</ISSNLinking>
        </MedlineJournalInfo>
        <ChemicalList>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000617">Aminoglycosides</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>0</RegistryNumber>
                <NameOfSubstance UI="D000900">Anti-Bacterial Agents</NameOfSubstance>
            </Chemical>
            <Chemical>
                <RegistryNumber>Z5N076G8YQ</RegistryNumber>
                <NameOfSubstance UI="D000077732">Fidaxomicin</NameOfSubstance>
            </Chemical>
        </ChemicalList>
        <CitationSubset>IM</CitationSubset>
        <MeshHeadingList>
            <MeshHeading>
                <DescriptorName UI="D000617" MajorTopicYN="N">Aminoglycosides</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000900" MajorTopicYN="N">Anti-Bacterial Agents</DescriptorName>
                <QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D003015" MajorTopicYN="N">Clostridium Infections</DescriptorName>
                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016360" MajorTopicYN="N">Clostridium difficile</DescriptorName>
                <QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D016638" MajorTopicYN="N">Critical Illness</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D000077732" MajorTopicYN="N">Fidaxomicin</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
            </MeshHeading>
            <MeshHeading>
                <DescriptorName UI="D010362" MajorTopicYN="N">Patients' Rooms</DescriptorName>
            </MeshHeading>
        </MeshHeadingList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>12</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>12</Month>
                <Day>24</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2015</Year>
                <Month>12</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25534722</ArticleId>
            <ArticleId IdType="pii">AAC.04268-14</ArticleId>
            <ArticleId IdType="doi">10.1128/AAC.04268-14</ArticleId>
            <ArticleId IdType="pmc">PMC4325788</ArticleId>
        </ArticleIdList>
        <ReferenceList>
            <Reference>
                <Citation>N Engl J Med. 2000 Feb 10;342(6):390-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">10666429</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2007 Aug 1;45(3):302-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17599306</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Chest. 2007 Aug;132(2):418-24</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">17573523</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2008 Jul;52(7):2403-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">18443120</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Infect Control Hosp Epidemiol. 2010 May;31(5):431-55</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">20307191</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>N Engl J Med. 2011 Feb 3;364(5):422-31</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21288078</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>PLoS One. 2013;8(9):e75658</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">24086603</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2011 Sep;55(9):4427-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21709084</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Ann Intern Med. 2011 Dec 20;155(12):839-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22184691</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>J Infect. 2012 Feb;64(2):131-47</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22178989</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Lancet Infect Dis. 2012 Apr;12(4):281-9</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22321770</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2012 Aug;55 Suppl 2:S121-6</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">22752860</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Antimicrob Agents Chemother. 2013 Sep;57(9):4501-5</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">23836168</ArticleId>
                </ArticleIdList>
            </Reference>
            <Reference>
                <Citation>Clin Infect Dis. 2011 Sep;53(5):440-7</Citation>
                <ArticleIdList>
                    <ArticleId IdType="pubmed">21844027</ArticleId>
                </ArticleIdList>
            </Reference>
        </ReferenceList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>